CXCR4 and CCL20 expression has been described in a variety of human neoplasms, including colorectal, lung, pancreatic and breast human adenocarcinomas, malignant glioma, leukemia, lymphoma and melanoma as well as by normal keratinocytes. Here, CCL20 is linked to adenocarcinoma.